119 results
Page 4 of 6
6-K
EX-1.1
098nhhd5tn 113rwq7p
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
6-K
EX-99.1
socmbc9 lk4n1pqq
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
424B5
0rjqvfxb
12 Apr 21
Prospectus supplement for primary offering
9:07am
424B5
1a04 2ndn33p
9 Apr 21
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
alqi 5786yhqavws
6 Apr 21
VBL Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
3:33pm
6-K
EX-99.3
ki0f ndhw
15 Jan 21
Ordinary Share Purchase Agreement
7:01am
424B5
v23io
15 Jan 21
Prospectus supplement for primary offering
7:00am
F-3
qioqeyzgf
30 Dec 20
Shelf registration (foreign)
4:17pm
424B3
0qy44ziiky7q7r5ukriq
16 Nov 20
Prospectus supplement
7:15am
6-K
jorwb yo4ofrusnu
16 Nov 20
Current report (foreign)
7:00am
6-K
EX-99.1
vjijz5m
13 Oct 20
VBL Therapeutics Announces Appointment of Marc Kozin as Vice Chairman of Board of Directors
8:30am
424B3
zdqrwc5p
26 Aug 20
Prospectus supplement
5:21pm
6-K
hhqq6y
13 Aug 20
Current report (foreign)
7:00am
6-K
EX-99.1
llikvwpujz1j3x0tc
12 Aug 20
Current report (foreign)
8:45am
F-1
5iatrg1vheb
1 Jun 20
Registration statement (foreign)
12:18pm
6-K
EX-99.2
fr1aci4u dpvcw
28 May 20
Notice of Annual General Meeting of Shareholders
9:14am
6-K
urw ze2ty4
14 May 20
Current report (foreign)
7:25am
6-K
EX-10.1
b639u 8t3w
12 May 20
Current report (foreign)
12:04pm
6-K
EX-4.1
kklboq73dxb9d4ezyf
12 May 20
Current report (foreign)
12:04pm